MSCs have beneficial effects in ARDS animal models, such as reducing lung injury and maintaining alveolar‐endothelial barrier homeostasis mediated by TGF‐β1, IDO, NO, IL‐1RA, KGF and IL‐10.6, 7. Here, IDO1 is linked to acute respiratory distress syndrome.